TY  - GEN 
AU  - Hermosilla, Jesús
AU  - Pérez Robles, Raquel
AU  - Salmerón García, Antonio
AU  - Casares Atienza, Salvador
AU  - Cabeza, José
AU  - Navas Iglesias, Natalia Africa
PY  - 2021
UR  - http://hdl.handle.net/10481/70551
AB  - A range of biopharmaceutical products are used to target Vascular Endothelial Growth Factor (VEGF), including Eylea (R) (aflibercept, AFL) and Zaltrap (R) (ziv-aflibercept, ziv-AFL). The first is indicated for ophthalmological diseases such as...
LA  - eng
PB  - Elsevier
KW  - Ziv-Aflibercept
KW  - Fc-fusion protein
KW  - Infusion bags
KW  - Stability study
TI  - Stability study over time of clinical solutions of ziv-aflibercept prepared in infusion bags using a proper combination of physicochemical and functional strategies
DO  - 10.1016/j.jpba.2021.114209
ER  -